A Novel Cancer Testis Antigen, A-Kinase Anchor Protein 4 (AKAP4) Is a Potential Biomarker for Breast Cancer

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Saini, Shikha ^a   Jagadish, Nirmala ^a   Gupta, Anju ^b   Bhatnagar, Amar ^c   Suri, Anil ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b Vidyasagar Institute of Mental Health and Neurosciences Hospital   (India)

^c SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

A KINASE ANCHOR PROTEIN 4; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; MESSENGER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

A KINASE ANCHOR PROTEIN 4 GENE; ANTIBODY TITER; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOMIC IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

A KINASE ANCHOR PROTEINS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84874287363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057095     Document Type: Article

References (36)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. Ca Cancer J Clin 2012 62: 10-29.
2. Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW, (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20: 1505-1510.
3. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, et al. (2007) American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25: 5287-5312.
4. Taplin S, Abraham L, Barlow WE, Fenton JJ, Berns EA, et al. (2008) Mammography facility characteristics associated with interpretive accuracy of screening mammography. J Natl Cancer Inst 100: 876-887.
5. Suri A, (2006) Cancer testis antigens-their importance in immunotherapy and in early detection of cancer. Expert Opin Biol Ther 6: 379-389.
6. Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, et al. (2007) Sperm associated antigen 9 (SPAG9), a novel cancer testis antigen is potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res 13: 1421-1428.
7. Garg M, Kanojia D, Khosla A, Dudha N, Sati S, et al. (2008) Sperm associated antigen 9 is associated with tumor growth, migration and invasion in renal cell carcinoma. Cancer Res 68: 8240-8248.
8. Kanojia D, Garg M, Gupta S, Gupta A, Suri A, (2009) Sperm associated antigen 9 (SPAG9), a novel biomarker for early detection of breast cancer. Cancer Epidem Biomarkers Prev 18: 630-639.
9. Garg M, Kanojia D, Salhan S, Suri S, Gupta A, et al. (2009) Sperm-associated antigen 9 (SPAG9) is a biomarker for early cervical carcinoma. Cancer 115: 2671-2683.
10. Garg M, Kanojia D, Suri S, Gupta S, Gupta A, et al. (2009) Sperm-associated antigen 9, a novel diagnostic marker for thyroid cancer. J Clin Endocrinol Metab 94: 4613-4618.
11. Kanojia D, Garg M, Saini S, Agarwal S, Suri A, (2010) Sperm associated antigen 9 expression and humoral response in chronic myeloid leukemia. Leuk Res 34: 858-863.
12. Kanojia D, Garg M, Gupta S, Gupta A, Suri A, (2011) Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity. Am J Pathol 178: 1009-1020.
13. Yu P, Yan L, Zhang H, Lin X, Zhao X, (2012) Expression and clinical significance of Sperm-Associated Antigen 9 in patients with endometrial carcinoma. Int J Gynaecol Cancer 22: 87-93.
14. Mohapatra B, Verma S, Shankar S, Suri A, (1998) Molecular cloning of human testis mRNA specifically expressed in haploid germ cells, having structural homology with the A-kinase anchoring proteins. Biochem Biophys Res Commun 244: 540-545.
15. Hofmann O, Caballero OL, Stevenson BJ, Chen Y, Cohen T, et al. (2008) Genome-wide analysis of cancer/testis gene expression. Proc Natl Acad Sci U S A 105: 20422-20427.
16. Gold MG, Lygren B, Dokurno P, Hoshi N, McConnachie G, et al. (2006) Molecular Basis of AKAP Specificity for PKA regulatory subunits. Mol Cell 24: 383-395.
17. Tortora G, Ciardiello F, (2002) Protein kinase A Type I: a target for cancer therapy. Clin Cancer Res 8: 303-304.
18. Amano H, Ando K, Minamida S, Hayashi I, Ogino M, et al. (2001) Adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo. Jpn J Pharmacol 87: 181-188.
19. Miller WR, (2002) Regulatory subunits of PKA and breast cancer. Ann N Y Acad Sci 968: 37-48.
20. Gu L, Lau SK, Loera S, Somlo G, Kane SE, (2009) Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines. Clin Cancer Res 15: 7196-7206.
21. Chiriva-Internati M, Raffaele F, Yu Y, Hamrick C, Gagliano N, et al. (2008) AKAP4: a novel cancer testis antigen for multiple myeloma. Br J Haematol 140: 464-474.
22. Chiriva-Internati M, Yu Y, Mirandola L, D'Cunha N, Hardwicke F, et al. (2012) Identification of AKAP4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. Prostate 72: 12-23.
23. Radhi S, Alalawi R, Mirandola L, Yu Y, Pandey A, et al. (2012) Novel tumor markers in non-small cell lung cancer detected both in serology and tissue. J Clin Oncol 30 suppl; abstr e21105.
24. Gu L, Lau SK, Loera S, Somlo G, Kane SE, (2009) Protein kinase A activation confers resistance to trastuzumab in human breast cancer cell lines. Clin Cancer Res 15: 7196-7206.
25. Megan Scudellari, (2011) a ballsy search for cancer targets. Nat Med 17: 916-918.
26. Miki K, Willis WD, Brown PR, Goulding EH, Fulcher KD, et al. (2002) Targeted disruption of the AKAP4 gene causes defects in sperm flagellum and motility. Dev Biol 48: 331-342.
27. Grigoriadisa A, Caballerob OL, Hoekc KS, Silvad L, Chene Y, et al. (2009) CT-X antigen expression in human breast cancer. Proc Natl Acad Sci U S A 106: 13493-13498.
28. Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Löning T, et al. (2001) MAGE-A gene expression pattern in primary breast cancer. Cancer Res 61: 6682-6687.
29. Sugita Y, Wada H, Fujita S, Nakata T, Sato S, et al. (2004) NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer Res 64: 2199-2204.
30. Kulasingam V, Diamandis EP, (2008) Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 5: 588-599.
31. Krüger S, Ola V, Feller AC, Fischer D, Friedrich M, (2007) Expression of cancer-testis antigen CT7 (MAGE-C1) in breast cancer: an immunohistochemical study with emphasis on prognostic utility. Pathol Oncol Res 13: 91-96.
32. Matković B, Juretić A, Spagnoli GC, Šeparović V, Gamulin M, et al. (2011) Expression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: a retrospective immunohistochemical study. Croat Med J 52: 171-177.
33. Chen YT, Ross DS, Chiu R, Zhou XK, Chen YY, et al. (2011) Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high- grade breast cancers. Plos One 2011 6: e17876.
34. Zhong L, Ge K, J Zu JC, Zhao LH, Shen WK, et al. (2008) Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res 10: R40.
35. Chapman C, Murray A, Chakrabarti J, Thorpel A, Woolston C, et al (2007) Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18: 868-873.
36. Mischo A, Kubuschok B, Ertan K, Preuss KD, Romeike B, et al. (2006) Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer. Int J Cancer 118: 696-703.